Compare PAYS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYS | MLAB |
|---|---|---|
| Founded | 2001 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 780.3M | 719.9M |
| IPO Year | 2020 | 1995 |
| Metric | PAYS | MLAB |
|---|---|---|
| Price | $12.67 | $133.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $9.42 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 717.7K | 102.9K |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | 85.71 | ★ 436.11 |
| EPS | 0.20 | ★ 0.49 |
| Revenue | ★ $24,120,434.00 | N/A |
| Revenue This Year | $33.83 | $6.07 |
| Revenue Next Year | $14.89 | $5.41 |
| P/E Ratio | ★ $64.55 | $274.76 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.08 | $63.48 |
| 52 Week High | $14.43 | $136.20 |
| Indicator | PAYS | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 63.86 |
| Support Level | $12.08 | $94.20 |
| Resistance Level | $13.70 | $132.70 |
| Average True Range (ATR) | 0.63 | 4.23 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 61.80 | 73.67 |
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.